Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Gallstone pharmaceutical composition and preparation method thereof

A composition and a technique for gallstones, applied in the directions of drug combinations, pharmaceutical formulations, medical raw materials derived from ferns/filamentous plants, etc., can solve the problems of slow effect, insignificant effect, easy recurrence of gallstones, etc., and achieve effective results. Fast, non-toxic and side effects, good effect of stone removal

Inactive Publication Date: 2016-07-06
李艳梅
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a pharmaceutical composition for gallstones, so as to overcome the shortcomings of easy recurrence, slow effect and insignificant effect in the existing treatment of gallstones

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] A pharmaceutical composition for gallstones, comprising: 20 parts of Desmodium, 15 parts of Curcuma, 8 parts of Eucommia, 9 parts of Citrus Fructus, 3 parts of Licorice, 20 parts of Radix Paeoniae Albizia, 15 parts of Albizia Julibrissin, gentian 11 parts of grass, 6 parts of pinellia, 9 parts of frankincense, 6 parts of Scutellaria barbata, 11 parts of astragalus, and 3 parts of Shiwei.

[0032] A preparation method of a gallstone pharmaceutical composition, comprising the following steps:

[0033] (1) Weigh the raw materials needed for production;

[0034] (2) For the first decoction, soak the raw medicine in water, then decoct with strong fire until boiling, then decoct with slow fire for 40 minutes, take out the medicine juice, and leave the remaining medicine residue;

[0035] (3) Decocting for the second time, adding water to the remaining medicinal residues in the step (2) for decocting, decocting with a slow fire for 50 minutes after the water boils, taking out...

Embodiment 2

[0038] The difference between this example and Example 1 is that a pharmaceutical composition for gallstones comprises, in parts by weight: 10 parts of Desmodium, 5 parts of Curcuma, 5 parts of Eucommia, 5 parts of Fructus Aurantii, 1 part of Licorice, 10 parts of peony, 5 parts of albizia juniper, 5 parts of gentian, 1 part of pinellia, 5 parts of frankincense, 1 part of Scutellaria barbata, 1 part of astragalus, and 1 part of Shiwei.

Embodiment 3

[0040] The difference between this example and Example 1 is that a pharmaceutical composition for gallstones comprises, in parts by weight: 30 parts of Desmodium, 20 parts of Curcuma, 15 parts of Eucommia, 15 parts of Fructus Aurantii, 5 parts of Licorice, 30 parts of peony, 20 parts of Albizia julibrissin, 15 parts of gentian, 10 parts of pinellia, 15 parts of frankincense, 1-10 parts of Scutellaria barbata, 15 parts of astragalus, and 5 parts of Shiwei.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a gallstone pharmaceutical composition which comprises the following components in parts by weight: 10-30 parts of longhairy antenoron herb, 5-20 parts of radix curcumae, 5-15 parts of eucommia ulmoides, 5-15 parts of fructus aurantii, 1-5 parts of liquorice, 10-30 parts of radix paeoniae alba, 5-20 parts of flos albiziae, 5-15 parts of radix geutianae, 1-10 parts of pinellia ternata, 5-15 parts of frankincense, 1-10 parts of sculellaria barbata, 1-15 parts of radix astragali and 1-5 parts of pyrrosia lingua. With a reasonable formula, the pharmaceutical composition for treating gallstone disclosed by the invention realizes the effects of soothing liver and promoting bile secretion and moving qi and relieving pain and has the advantages of good stone removal effect, fast effect, short treatment course and no toxic or side effect when being used for treating hepatolithiasis and gallstone symptoms. Moreover, the preparation method is simple and convenient to operate.

Description

technical field [0001] The invention relates to the field of gallstone treatment, in particular to a gallstone pharmaceutical composition and a preparation method thereof. Background technique [0002] Cholelithiasis, also known as cholelithiasis, refers to a disease in which stones occur in the biliary system, including the gallbladder or bile duct; biliary tract infection is a common disease. Divided into cholecystitis and cholangitis according to the site of onset. After the stones form in the gallbladder, they can stimulate the gallbladder mucosa, which can not only cause chronic inflammation of the gallbladder, but also cause secondary infection when the stones are incarcerated in the neck of the gallbladder or the cystic duct, leading to acute inflammation of the gallbladder. Chronic stimulation of the gallbladder mucosa by stones may also lead to the occurrence of gallbladder cancer. It has been reported that the incidence of gallbladder cancer can reach 1% to 2%. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P1/16
CPCA61K36/185A61K9/0095A61K36/11A61K36/324A61K36/46A61K36/48A61K36/481A61K36/484A61K36/515A61K36/53A61K36/539A61K36/65A61K36/71A61K36/752A61K36/8888A61K36/9066A61K2236/331A61K2236/39A61K2300/00
Inventor 李艳梅
Owner 李艳梅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com